Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bittner

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Blood|March 2, 2006
c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cellsJay L Hess, Claudia B Bittner, Deniz T Zeisig, et al.
Transplantation Proceedings|April 26, 2005
C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipientsM J Barten, A Rahmel, J Garbade, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failureD Q. Nguyen, S Ormaza, L W. Miller, et al.
International Immunopharmacology|December 13, 2006
Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantationMarkus J Barten, Jens Garbade, Hartmuth B Bittner, et al.
Transplantation Proceedings|January 3, 2006
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipientsM J Barten, A Rahmel, J Garbade, et al.
Journal of Immunological Methods|December 9, 2003
Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human bloodMarkus J Barten, Stefan Dhein, Hubert Chang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 23, 2016
Effect of confounding factors on a phospho-flow assay of ribosomal S6 protein for therapeutic drug monitoring of the mTOR-inhibitor everolimus in heart transplanted patientsMaja-Theresa Dieterlen, Katja John, Susanne Haase, et al.
Computers in Biology and Medicine|December 22, 2006
Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart transplantation: whole blood flow cytometric analysis of lymphocyte functionMarkus J Barten, Axel Rahmel, Andreas Boldt, et al.
Perfusion|July 4, 2014
Fate of patients with extracorporeal lung assist as a bridge to lung transplantation versus patients without--a single-center experienceS Lehmann, M Uhlemann, S Leontyev, et al.
Circulation|November 1, 1995
Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death--related cardiac dysfunctionH B Bittner, E P Chen, C A Milano, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Blood|March 2, 2006
c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cellsJay L Hess, Claudia B Bittner, Deniz T Zeisig, et al.
Transplantation Proceedings|April 26, 2005
C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipientsM J Barten, A Rahmel, J Garbade, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failureD Q. Nguyen, S Ormaza, L W. Miller, et al.
International Immunopharmacology|December 13, 2006
Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantationMarkus J Barten, Jens Garbade, Hartmuth B Bittner, et al.
Transplantation Proceedings|January 3, 2006
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipientsM J Barten, A Rahmel, J Garbade, et al.
Journal of Immunological Methods|December 9, 2003
Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human bloodMarkus J Barten, Stefan Dhein, Hubert Chang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 23, 2016
Effect of confounding factors on a phospho-flow assay of ribosomal S6 protein for therapeutic drug monitoring of the mTOR-inhibitor everolimus in heart transplanted patientsMaja-Theresa Dieterlen, Katja John, Susanne Haase, et al.
Computers in Biology and Medicine|December 22, 2006
Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart transplantation: whole blood flow cytometric analysis of lymphocyte functionMarkus J Barten, Axel Rahmel, Andreas Boldt, et al.
Perfusion|July 4, 2014
Fate of patients with extracorporeal lung assist as a bridge to lung transplantation versus patients without--a single-center experienceS Lehmann, M Uhlemann, S Leontyev, et al.
Circulation|November 1, 1995
Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death--related cardiac dysfunctionH B Bittner, E P Chen, C A Milano, et al.
Pageof 15